RBC Capital Boosts Price Target on Regeneron Pharmaceuticals (NASDAQ:REGN) to $820 From $818
RBC Capital Boosts Price Target on Regeneron Pharmaceuticals (NASDAQ:REGN) to $820 From $818, Keeps Sector Perform Rating.
Royal Bank of Canada
Royal Bank of Canada (NYSE:RY) is a global financial institution with a purpose-driven, principles-led approach to delivering leading performance. Our success comes from the 97,000+ employees who leverage their imaginations and insights to bring our vision, values and strategy to life so we can help our clients thrive and communities prosper. As Canada’s biggest bank, and one of the largest in the world based on market capitalization, we have a diversified business model with a focus on innovation and providing exceptional experiences to our 17 million clients in Canada, the U.S. and 27 other countries.
RBC Capital Cuts Price Target on CVS Health (NYSE:CVS) to $91 From $102
RBC Capital Cuts Price Target on CVS Health (NYSE:CVS) to $91 From $102, Maintains Outperform Rating.
RBC Capital Cuts Price Target on CVS Health (NYSE:CVS) to $91 From $102 Read Post »
RBC Capital Boosts Price Target on Emerson Electric (NYSE:EMR) to $111 From $103
RBC Capital Boosts Price Target on Emerson Electric (NYSE:EMR) to $111 From $103, Maintains Outperform Rating.
RBC Capital Boosts Price Target on Emerson Electric (NYSE:EMR) to $111 From $103 Read Post »
RBC Capital Boosts Price Target on DuPont De Nemours (NYSE:DD) to $90 From $81
RBC Capital Boosts Price Target on DuPont De Nemours (NYSE:DD) to $90 From $81, Maintains Outperform Rating.
RBC Capital Boosts Price Target on DuPont De Nemours (NYSE:DD) to $90 From $81 Read Post »
RBC Capital maintains Colgate-Palmolive (NYSE:CL) $83 price target
RBC Capital analyst Nik Modi reiterates Colgate-Palmolive (NYSE:CL) with a Sector Perform and maintains $83 price target.
RBC Capital maintains Colgate-Palmolive (NYSE:CL) $83 price target Read Post »
RBC Capital maintains Weyerhaeuser (NYSE:WY) $40 price target
RBC Capital analyst Paul Quinn reiterates Weyerhaeuser (NYSE:WY) with a Outperform and maintains $40 price target.
RBC Capital maintains Weyerhaeuser (NYSE:WY) $40 price target Read Post »
RBC Capital announces CSX (NASDAQ:CSX) $35 price target
RBC Capital analyst Walter Spracklin downgrades CSX (NASDAQ:CSX) from Outperform to Sector Perform and announces $35 price target.
RBC Capital announces CSX (NASDAQ:CSX) $35 price target Read Post »
RBC Capital maintains Boeing (NYSE:BA) $225 price target
RBC Capital analyst Ken Herbert reiterates Boeing (NYSE:BA) with a Sector Perform and maintains $225 price target.
RBC Capital maintains Boeing (NYSE:BA) $225 price target Read Post »
RBC Capital Lifts Price Target on Honeywell (NASDAQ:HON) to $211 From $210
RBC Capital Lifts Price Target on Honeywell International (NASDAQ:HON) to $211 From $210, Maintains Sector Perform Rating.
RBC Capital Lifts Price Target on Honeywell (NASDAQ:HON) to $211 From $210 Read Post »
RBC Capital Boosts Price Target on F5 (NASDAQ:FFIV) to $173 From $146
RBC Capital Boosts Price Target on F5 (NASDAQ:FFIV) to $173 From $146, Sees ‘Early Signs of Demand Stabilization,’ Maintains Sector Perform Rating.
RBC Capital Boosts Price Target on F5 (NASDAQ:FFIV) to $173 From $146 Read Post »
RBC Capital Boosts Price Target on Roper Technologies (NASDAQ:ROP) to $569 From $532
RBC Capital Boosts Price Target on Roper Technologies (NASDAQ:ROP) to $569 From $532 on Q2 Beat, Full-Year Guidance Increase; Outperform Kept.
RBC Capital Boosts Price Target on Roper Technologies (NASDAQ:ROP) to $569 From $532 Read Post »
RBC Capital raises ServiceNow (NYSE:NOW) price target from $540 to $650
RBC Capital analyst Matthew Hedberg maintains ServiceNow (NYSE:NOW) with a Outperform and raises the price target from $540 to $650.
RBC Capital raises ServiceNow (NYSE:NOW) price target from $540 to $650 Read Post »